Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Jump to section
Related Articles
Cited By...
- Short- versus long-term Dual AntiPlatelet Therapy for Stent-Assisted treatment of CErebral aneurysm (DAPTS ACE): a multicenter, open-label, randomized clinical trial
- Short- versus long-term Dual AntiPlatelet Therapy for Stent-Assisted treatment of CErebral aneurysm (DAPTS ACE): a multicenter, open-label, randomized clinical trial
- Safety of Oral P2Y12 Inhibitors in Interventional Neuroradiology: Current Status and Perspectives
- Active management of the target P2Y12 reaction unit range in patients undergoing stent-assisted coil embolization for unruptured cerebral aneurysms
- Dose adjustment of clopidogrel in hyper-responder patients with unruptured intracranial aneurysms treated with stents
- Platelet reactivity and hemorrhage risk in neurointerventional procedures under dual antiplatelet therapy
- Platelet function testing: does a randomized controlled trial settle the debate?
- Association between CYP2C19 Polymorphisms and Outcomes in Cerebral Endovascular Therapy
- Platelet Testing is Associated with Worse Clinical Outcomes for Patients Treated with the Pipeline Embolization Device
- Use of thromboelastography to tailor dual-antiplatelet therapy in patients undergoing treatment of intracranial aneurysms with the Pipeline embolization device
- Tailoring platelet inhibition according to multiple electrode aggregometry decreases the rate of thrombotic complications after intracranial flow-diverting stent implantation
- Prospective Study of Early MRI Appearances following Flow-Diverting Stent Placement for Intracranial Aneurysms
- Variability in initial response to standard clopidogrel therapy, delayed conversion to clopidogrel hyper-response, and associated thromboembolic and hemorrhagic complications in patients undergoing endovascular treatment of unruptured cerebral aneurysms
- Platelet function inhibitors and platelet function testing in neurointerventional procedures
- Carotid artery stenting outcomes: do they correlate with antiplatelet response assays?
- Last-Recorded P2Y12 Reaction Units Value Is Strongly Associated with Thromboembolic and Hemorrhagic Complications Occurring Up to 6 Months after Treatment in Patients with Cerebral Aneurysms Treated with the Pipeline Embolization Device
- Point of care platelet function testing in routine neurointerventional care is unjustified
- Antiplatelet testing in neurointervention: we cannot ignore the signs
- Platelet-Function Testing in Patients Undergoing Neurovascular Procedures: Caught between a Rock and a Hard Place